7:45am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The short interest data are out for the October 30 settlement date, and short interest fell in selected biotech stocks.
Companies
/Healthcare
AMGEN Inc
$377.35
▼ $5.12 (−1.34%) today
Markets closed · 12:02am ET
AMGN Coverage
Page 274:41pm ET
Health and Healthcare
Amgen Beats Earnings With Solid Outlook For 2015
ThinkstockAmgen Inc. (NASDAQ: AMGN) released its third quarter earnings report Wednesday after the markets closed. The biotech giant had $2.72 in earnings per share (EPS) on $5.72 billion in revenue compared to…
Chris Lange 11:25am ET
Health and Healthcare
What to Expect From Amgen Earnings
Amgen is scheduled to report its third-quarter financial results after the markets close on Wednesday.
Chris Lange 8:10am ET
Health and Healthcare
Short Sellers Become More Selective on Leading Biotechs
The October 15 short interest data have been compared with the previous figures, and short interest mixed in these selected biotech stocks.
1:35pm ET
Health and Healthcare
Why Amgen’s Future Is Looking Bright
Amgen is slowly getting closer to an FDA final decision for its first-of-a-kind cancer therapy, talimogene laherparepvec (T-Vec).
Chris Lange 10:05am ET
Health and Healthcare
Q3 Worst for Biotech in 7 Years: Which Large Cap Leaders to Buy Now
Cowen says the way to play biotech is with large cap sector leaders that can beat earnings estimates. It also thinks third-quarter earnings beats could highlight the risk of not owning biotech…
8:20am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotechs
The September 30 short interest data have been compared with the previous figures, and short interest increased in most of these selected biotech stocks for this settlement date.
10:05am ET
Health and Healthcare
UBS Loves These 3 Top Biotech Stock Leaders Into Q3 Earnings
Given the massive beat-down in the sector, if these companies surpass earnings expectations, the upside could be sizable.
11:25am ET
Health and Healthcare
Independent Research Sees 3 Top Health and Biotech Stocks as Oversold
Independent research firm Argus has reviews of three of health care picks from its own Focus List in which it still sees significant upside ahead.
9:25am ET
Health and Healthcare
How the Top Biotechs Handled the Valuation Shock
24/7 Wall St. has taken a look at some of the largest biotech companies and highlighted the damage that a single tweet did to them last week.
8:05am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotech
The September 15 short interest data have been compared with the previous figures, and short interest in these selected stocks increased across the board for this settlement date.
1:20pm ET
Health and Healthcare
Fitch: Gradual Conversion Begins as First Biosimilar Hits US Market
According to Fitch Ratings, biosimilars are beginning to take share from their reference biologics. This is seen in the debut of the first biosimilar drug in the United States.
Chris Lange 11:05am ET
Health and Healthcare
Meet the Newest Biotech Collaboration: Amgen and Xencor
Amgen and Xencor have entered into a research and license agreement to develop and commercialize novel therapeutics in the areas of cancer immunotherapy and inflammation.
Chris Lange 8:05am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotechs
The short interest data are out for the August 31 settlement date. Short interest in the selected biotech stocks increased across the board for this settlement date.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Amgen, Dow, Fitbit, Office Depot, SanDisk, Wells Fargo, Yum and Many More
Tuesday’s top analyst upgrades, downgrades and initiations include Amgen, Dow Chemical, Fitbit, Office Depot, SanDisk, Wells Fargo and Yum! Brands.